RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+3.6%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$955M
AUM Growth
+$955M
(+8.5%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
94
New
8
Increased
32
Reduced
32
Closed
4
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$13.5M |
| 2 |
Becton Dickinson
BDX
|
$9.44M |
| 3 |
Biogen
BIIB
|
$9.29M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$8.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
$7.92M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$14.9M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$12.2M |
| 3 |
Cigna
CI
|
$11.6M |
| 4 |
Elevance Health
ELV
|
$9.3M |
| 5 |
Pfizer
PFE
|
$8.84M |
Sector Composition
| 1 | Healthcare | 98.85% |
| 2 | Industrials | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
51
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.68M | 0.7% |
378,000
+53,000
| +16% | +$936K |
|
|
IMGN
52
DELISTED
Immunogen Inc
IMGN
| $6.53M | 0.68% |
1,100,000
-100,000
| -8% | -$594K |
|
|
SWAV
53
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.86M | 0.61% |
20,000
-50,978
| -72% | -$14.9M |
|
54
Veeva Systems
VEEV
$44.4B
| $5.79M | 0.61% |
34,500
-3,500
| -9% | -$588K |
|
|
ITCI
55
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.71M | 0.6% |
125,000
-15,000
| -11% | -$685K |
|
56
Outset Medical
OM
$245M
| $5.28M | 0.55% |
340,000
+160,000
| +89% | +$2.49M |
|
|
SGEN
57
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.21M | 0.55% |
41,000
-4,208
| -9% | -$535K |
|
58
Agilon Health
AGL
$497M
| $5.06M | 0.53% |
255,000
+90,000
| +55% | +$1.79M |
|
59
Glaukos
GKOS
$5.42B
| $4.77M | 0.5% |
85,000
-4,991
| -6% | -$280K |
|
60
Iovance Biotherapeutics
IOVA
$800M
| $4.76M | 0.5% |
510,000
-20,000
| -4% | -$187K |
|
61
Envista
NVST
$3.37B
| $4.75M | 0.5% |
+143,800
| New | +$4.75M |
|
|
KRTX
62
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.39M | 0.46% |
+20,000
| New | +$4.39M |
|
|
VRAY
63
DELISTED
ViewRay, Inc.
VRAY
| $4.29M | 0.45% |
1,000,000
| – | – |
|
64
MeiraGTx Holdings
MGTX
$590M
| $4.04M | 0.42% |
555,030
+55,030
| +11% | +$400K |
|
65
Progyny
PGNY
$2.02B
| $4M | 0.42% |
90,000
| – | – |
|
|
GTHX
66
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.94M | 0.41% |
370,000
+53,863
| +17% | +$574K |
|
67
West Pharmaceutical
WST
$17.9B
| $3.91M | 0.41% |
+17,000
| New | +$3.91M |
|
68
Teladoc Health
TDOC
$1.37B
| $3.85M | 0.4% |
130,000
+45,000
| +53% | +$1.33M |
|
69
Natera
NTRA
$23B
| $3.76M | 0.39% |
+80,000
| New | +$3.76M |
|
70
Alignment Healthcare
ALHC
$3.23B
| $3.64M | 0.38% |
+274,950
| New | +$3.64M |
|
71
Sangamo Therapeutics
SGMO
$161M
| $3.6M | 0.38% |
820,000
+120,000
| +17% | +$527K |
|
|
OLK
72
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.56M | 0.37% |
194,390
+54,390
| +39% | +$997K |
|
73
Allogene Therapeutics
ALLO
$249M
| $3.5M | 0.37% |
340,000
-10,000
| -3% | -$103K |
|
74
Phreesia
PHR
$1.81B
| $3.42M | 0.36% |
125,000
+50,000
| +67% | +$1.37M |
|
75
Alkermes
ALKS
$4.95B
| $3.41M | 0.36% |
150,000
| – | – |
|